A subset of tumor-infiltrating lymphocytes (TIL) with several properties in common with TRM, including the expression of the CD103 integrin and CD69, has recently been identified in human tumors, including ovarian, lung and breast tumors, and melanoma (15–19). Here, CD69 is linked to neoplasm.